Yale New Haven Hospital ( Site 1012) — New Haven, Connecticut

Yale New Haven Hospital ( Site 1012) is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Yale New Haven Hospital ( Site 1012) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale New Haven Hospital ( Site 1012)?

Yale New Haven Hospital ( Site 1012) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale New Haven Hospital ( Site 1012) conducted?

Yale New Haven Hospital ( Site 1012) has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma.

Is Yale New Haven Hospital ( Site 1012) accredited by Crixeo Health?

Yale New Haven Hospital ( Site 1012) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale New Haven Hospital ( Site 1012)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.